Hana Pharm Co., Ltd. (KRX:293480)
South Korea · Delayed Price · Currency is KRW 10,760
-250 (-2.27%)
Feb 20, 2026, 3:30 PM KST
Hana Pharm Market Cap
Hana Pharm has a market cap or net worth of 191.24 billion as of February 20, 2026. Its market cap has increased by 3.56% in one year.
Market Cap
191.24B
Enterprise Value
n/a
Revenue
139.33B
Ranking
n/a
PE Ratio
4.80
Stock Price
10,760.00
Market Cap Chart
Since October 2, 2018, Hana Pharm's market cap has decreased from 537.03B to 191.24B, a decrease of -64.39%. That is a compound annual growth rate of -13.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 191.24B | -4.10% |
| Dec 30, 2025 | 199.41B | 2.94% |
| Dec 30, 2024 | 193.73B | -21.86% |
| Dec 28, 2023 | 247.93B | -23.56% |
| Dec 29, 2022 | 324.36B | -9.43% |
| Dec 30, 2021 | 358.12B | -14.15% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HLB Pharmaceutical | 234.08B |
| Ilyang Pharmaceutical Co.,Ltd | 233.92B |
| AptaBio Therapeutics | 224.75B |
| Jeil Pharmaceutical Co.,Ltd | 213.91B |
| REYON Pharmaceutical | 209.09B |
| JW Lifescience | 208.73B |
| SAMSUNG PHARM. Co., LTD. | 204.24B |
| Ilsung Is | 183.63B |